Australia markets closed
  • ALL ORDS

    7,239.40
    +30.40 (+0.42%)
     
  • ASX 200

    7,014.20
    +31.50 (+0.45%)
     
  • AUD/USD

    0.7742
    +0.0012 (+0.15%)
     
  • OIL

    64.39
    +0.57 (+0.89%)
     
  • GOLD

    1,834.30
    +10.30 (+0.56%)
     
  • BTC-AUD

    65,327.95
    +1,334.32 (+2.09%)
     
  • CMC Crypto 200

    1,401.52
    +13.61 (+0.98%)
     
  • AUD/EUR

    0.6389
    -0.0005 (-0.07%)
     
  • AUD/NZD

    1.0736
    -0.0016 (-0.15%)
     
  • NZX 50

    12,367.86
    -60.26 (-0.48%)
     
  • NASDAQ

    13,109.15
    +107.51 (+0.83%)
     
  • FTSE

    7,008.53
    +45.20 (+0.65%)
     
  • Dow Jones

    34,021.45
    +433.79 (+1.29%)
     
  • DAX

    15,292.64
    +92.96 (+0.61%)
     
  • Hang Seng

    28,027.57
    +308.90 (+1.11%)
     
  • NIKKEI 225

    28,084.47
    +636.46 (+2.32%)
     

Moderna sees shortfall in Britain COVID vaccine shipments, EU deliveries on track

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
  • Oops!
    Something went wrong.
    Please try again later.

ZURICH, April 16 (Reuters) - U.S. drugmaker Moderna expects a shortfall in COVID-19 vaccine doses from its European supply chain hitting second-quarter delivery quantities for Britain and Canada, though European Union- and Swiss-bound shipments are on track, a spokesperson said.

The delays, first announced on Friday when Canada said Moderna would be delivering only about half the planned 1.2 million doses by the end of April, come as Switzerland's Lonza ramps up three new production lines to make active ingredients for Moderna vaccine supplies outside of the United States.

"The trajectory of vaccine manufacturing ramp-up is not linear, and despite best efforts, there is a shortfall in previously estimated doses from the European supply chain," Moderna said in a statement.

Lonza didn't immediately return a phone call and email seeking comment on any issues in its production. (Reporting by John Miller; editing by David Evans)